107 related articles for article (PubMed ID: 16290149)
1. Development of chemically stable solid phases for the target isolation with reduced nonspecific binding proteins.
Takahashi T; Shiyama T; Hosoya K; Tanaka A
Bioorg Med Chem Lett; 2006 Jan; 16(2):447-50. PubMed ID: 16290149
[TBL] [Abstract][Full Text] [Related]
2. Isolating the whole complex of target proteins of FK506 using affinity resins from novel solid phases.
Takahashi T; Shiyama T; Mori T; Hosoya K; Tanaka A
Anal Bioanal Chem; 2006 May; 385(1):122-7. PubMed ID: 16601955
[TBL] [Abstract][Full Text] [Related]
3. Reduction of nonspecific binding proteins to self-assembled monolayer on gold surface.
Furuya M; Haramura M; Tanaka A
Bioorg Med Chem; 2006 Jan; 14(2):537-43. PubMed ID: 16314102
[TBL] [Abstract][Full Text] [Related]
4. A quantitative analysis and chemical approach for the reduction of nonspecific binding proteins on affinity resins.
Tamura T; Terada T; Tanaka A
Bioconjug Chem; 2003; 14(6):1222-30. PubMed ID: 14624639
[TBL] [Abstract][Full Text] [Related]
5. Selective ligand purification using high-performance affinity beads.
Ohtsu Y; Ohba R; Imamura Y; Kobayashi M; Hatori H; Zenkoh T; Hatakeyama M; Manabe T; Hino M; Yamaguchi Y; Kataoka K; Kawaguchi H; Watanabe H; Handa H
Anal Biochem; 2005 Mar; 338(2):245-52. PubMed ID: 15745744
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a cell model based on FKBP12 dimerization for screening of FK506-like neurotrophic small molecular compounds.
Xiao H; Wang LL; Shu CL; Yu M; Li S; Shen BF; Li Y
J Biomol Screen; 2006 Apr; 11(3):225-35. PubMed ID: 16490780
[TBL] [Abstract][Full Text] [Related]
7. Selective elution of target protein from affinity resins by a simple reductant with a thiol group.
Mabuchi M; Haramura M; Shimizu T; Nishizaki T; Tanaka A
Bioorg Med Chem Lett; 2010 Dec; 20(24):7361-4. PubMed ID: 21067925
[TBL] [Abstract][Full Text] [Related]
8. Differential responses of the backbone and side-chain conformational dynamics in FKBP12 upon binding the transition-state analog FK506: implications for transition-state stabilization and target protein recognition.
Brath U; Akke M
J Mol Biol; 2009 Mar; 387(1):233-44. PubMed ID: 19361439
[TBL] [Abstract][Full Text] [Related]
9. Improvement of monolithic solid material by utilization of spacer for identification of the target using affinity resins.
Iwaoka E; Mori T; Shimizu T; Hosoya K; Tanaka A
Bioorg Med Chem Lett; 2009 Mar; 19(5):1469-72. PubMed ID: 19201607
[TBL] [Abstract][Full Text] [Related]
10. A versatile method of identifying specific binding proteins on affinity resins.
Yamamoto K; Yamazaki A; Takeuchi M; Tanaka A
Anal Biochem; 2006 May; 352(1):15-23. PubMed ID: 16540075
[TBL] [Abstract][Full Text] [Related]
11. Identification of small molecule binding molecules by affinity purification using a specific ligand immobilized on PEGA resin.
Kuramochi K; Miyano Y; Enomoto Y; Takeuchi R; Ishi K; Takakusagi Y; Saitoh T; Fukudome K; Manita D; Takeda Y; Kobayashi S; Sakaguchi K; Sugawara F
Bioconjug Chem; 2008 Dec; 19(12):2417-26. PubMed ID: 19035789
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of novel hydrophilic spacers for the reduction of nonspecific binding proteins on affinity resins.
Shiyama T; Furuya M; Yamazaki A; Terada T; Tanaka A
Bioorg Med Chem; 2004 Jun; 12(11):2831-41. PubMed ID: 15142543
[TBL] [Abstract][Full Text] [Related]
13. Intraligand hydrophobic interactions rationalize drug affinities for peptidyl-prolyl cis-trans isomerase protein.
Bizzarri M; Marsili S; Procacci P
J Phys Chem B; 2011 May; 115(19):6193-201. PubMed ID: 21500789
[TBL] [Abstract][Full Text] [Related]
14. Nuclear magnetic resonance fragment-based identification of novel FKBP12 inhibitors.
Stebbins JL; Zhang Z; Chen J; Wu B; Emdadi A; Williams ME; Cashman J; Pellecchia M
J Med Chem; 2007 Dec; 50(26):6607-17. PubMed ID: 18038971
[TBL] [Abstract][Full Text] [Related]
15. Improvement of solid material for affinity resins by application of long PEG spacers to capture the whole target complex of FK506.
Mabuchi M; Shimizu T; Ueda M; Mitamura K; Ikegawa S; Tanaka A
Bioorg Med Chem Lett; 2015 Jul; 25(14):2788-92. PubMed ID: 26025877
[TBL] [Abstract][Full Text] [Related]
16. Identification of the specific binding proteins of bioactive small compound using affinity resins.
Tanaka A
Methods Mol Biol; 2009; 577():181-95. PubMed ID: 19718517
[TBL] [Abstract][Full Text] [Related]
17. The full electron structure of the FKBP12/FK506 complex.
Rossetto AM; Zhou W; Pang X; Zhou L
J Biomol Struct Dyn; 2015; 33(2):388-94. PubMed ID: 24471694
[TBL] [Abstract][Full Text] [Related]
18. Structural characterization of the RyR1-FKBP12 interaction.
Samsó M; Shen X; Allen PD
J Mol Biol; 2006 Mar; 356(4):917-27. PubMed ID: 16405911
[TBL] [Abstract][Full Text] [Related]
19. The serpins alpha-1-antitrypsin and alpha-1-antichymotrypsin specifically interact with immunophilins.
Feldkämper I; Verspohl EJ; Neye H
Pharmazie; 2003 Nov; 58(11):811-6. PubMed ID: 14664338
[TBL] [Abstract][Full Text] [Related]
20. FK506-binding protein ligands: structure-based design, synthesis, and neurotrophic/neuroprotective properties of substituted 5,5-dimethyl-2-(4-thiazolidine)carboxylates.
Zhao L; Huang W; Liu H; Wang L; Zhong W; Xiao J; Hu Y; Li S
J Med Chem; 2006 Jul; 49(14):4059-71. PubMed ID: 16821768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]